Cardiovascular Disease Doctors in Hamilton, OH Accepting Medicare

7 Cardiovascular Disease doctors found. Showing 1 - 7

Sateesh Kesari, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Cereal Ave, Suite 207, Hamilton, OH 45013 Phone: 513-867-3331    Fax: 513-867-2667

Ravi Gurujal, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Cereal Ave Ste 207, Hamilton, OH 45013 Phone: 513-867-3331    Fax: 513-867-2667

Sukhchain Singh, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Cereal Ave Ste 207, Hamilton, OH 45013 Phone: 513-867-3331    Fax: 513-867-2667

Dr. George T. Manitsas, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1380 Nw Washington Blvd, Hamilton, OH 45013 Phone: 513-863-5592    Fax: 513-863-6772

Dr. Rajmohan S Karnik, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 10 Office Park Dr, Ste A, Hamilton, OH 45013 Phone: 513-768-2100    Fax: 513-737-8200

Patrick J. Lytle, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Cereal Ave, Suite 207, Hamilton, OH 45013 Phone: 513-867-3331    Fax: 513-867-2667

Mr. Parthiv R Shah, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1010 Cereal Ave, Suite 207, Hamilton, OH 45013 Phone: 513-867-3331    Fax: 513-867-2667

News Archive

U of O introduces Refugees and Global Health online program in Canada

All Canadian medical students, residents and practitioners now have full access to an innovative Web-based tool to enhance their understanding of medical care for refugees and new Canadians.

Endologix, LeMaitre Vascular announce early termination agreement for aortic endovascular products in Europe

Endologix, Inc., developer and marketer of minimally invasive treatments for aortic disorders, and LeMaitre Vascular, Inc., provider of peripheral vascular devices and implants, announced today that the companies have entered into an early termination agreement for LeMaitre's distribution rights of Endologix's aortic endovascular products in Europe.

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.

New non-surgical procedure can cure irregular heart rhythm

A new procedure can now treat esophageal perforations (holes in the esophagus) when caught early, therefore greatly reducing mortality rates.

Read more Medical News

› Verified 6 days ago